Huntington disease (HD) is an autosomal dominant, neurodegenerative disease caused by a CAG repeat expansion within the coding sequence of the HTT gene, resulting in a highly toxic protein with an expanded polyglutamine stretch that forms typical protein aggregates throughout the brain. We generated human induced pluripotent stem cells (hiPSCs) from two HD patients using non-integrating Sendai virus (SeV). The hiPSCs display a normal karyotype, express all pluripotency markers, have the same CAG repeat expansion as the original fibroblasts and are able to differentiate into the three germ layers in vitro.
Resource utility
The newly generated hiPSCs are useful to study HD disease mechanisms. Furthermore, these cells can be used for disease modelling and drug discovery studies.
Resource details
Huntington Disease (HD) is an autosomal dominant, neurodegenerative disease, clinically characterized by motor disturbances, especially chorea (i.e. involuntary and unpredictable body movements), behavioral and psychiatric symptoms and cognitive decline (Roos, 2010) . As the disease progresses, degeneration can be seen throughout the brain, but the main affected brain regions are the striatum and cerebral cortex (Gusella et al., 1983) . HD is caused by a CAG repeat expansion in the first exon of the huntingtin (HTT) gene on chromosome 4p16.3. The HTT RNA is translated into a highly toxic huntingtin protein with an expanded stretch of glutamine amino acids that aggregates throughout the brain.
Skin biopsies were obtained from two symptomatic HD patients; a 51 year old male (CAG repeat 18/46, age of onset 47) and a 49 year old female (CAG repeat 19/46, age of onset 47). The obtained skin fibroblasts were succesfully reprogrammed into hiPSCs using a replicationdefective and persistent Sendai virus (SeV) vector installed with OCT4, SOX2, KLF4 and c-Myc (Nishimura et al., 2011) . The hiPSC clones derived from the male were named LUMCi007-A and B and the hiPSCs derived from the female were named LUMCi008-A, B and C (Table 1) . All hiPSC clones showed typical hiPSC-like morphology with small and tightly packed cells, a high nucleus to cytoplasm ratio and well defined nucleoli (Fig. 1A ) and were SeV negative at passage 5 as shown by immunofluorescent staining (Supplementary Fig. S1A ) and RT-qPCR (data not shown). All clones stained positive for pluripotency markers OCT3/4, NANOG and SSEA-4 (Fig. 1B) . Accordingly, the hiPSCs showed, compared to the original fibroblasts, upregulated expression of pluripotency genes OCT3/4, NANOG and SOX2 (Fig. 1C) . A routine Global Screening Array (GSA) showed no major allelic changes in the hiPSC clones, tested at passage 5-6 (Fig. 1D) . Furthermore, the newly generated hiPSCs were identical to their original fibroblasts as shown by comparison of the allelic calls ( Supplementary Fig. S1B ). The CAG repeat size of the new hiPSC lines was confirmed by PCR ( Fig. 1E T box 17 (SOX17), the mesodermal marker smooth muscle actin (SMA), the ectodermal marker β3-tubulin (TUBB3) as confirmed by immunofluorescent staining (Fig. 1F) . Finally, all cells tested negative for mycoplasma (Supplementary Fig. S1C ). All the above mentioned data are presented in Table 2 .
Materials and methods

Ethical statement
This study was approved by the LUMC scientific ethical committee and informed consent was obtained from the two HD patients (NL45478.058.13/P13.080).
Generation of hiPSCs
A skin biopsy was obtained from a 51 year old male and a 49 year old female. Both with symptomatic HD. After dissection, fibroblasts were cultured in DMEM/F12 medium containing Glutamax, 10% Foetal Bovine Serum (FBS), Non-Essential Amino Acids (NEAA), 2-mercaptoethanol, Pen/Strep (all Gibco) and fresh 0.01 mg/ml vitamin C (Sigma) at 37°C and 5% CO 2 . Fibroblasts were expanded to passage 3 and subsequently used for reprogramming. For this, 1 × 10 5 fibroblasts were transduced with 7.5 MOI SeVdp(KOSM)302 L (Nishimura et al., 2011) and seeded on irradiated mouse embryonic fibroblasts (MEFs) in fibroblast medium. The next day, medium was changed to DMEM/F12 medium containing Glutamax, 20% KnockOut Serum Replacement (KOSR), Non-Essential Amino Acids (NEAA), 2-mercaptoethanol, Pen/ Strep (Gibco) and 10 ng/ml bFGF (Peprotech) until hiPSC colonies formed after approximately 3 weeks. hiPSC colonies were excised manually and expanded on Vitronectin XF coated plates in TESR-E8 medium (STEMCELL Technologies), resulting in 2 and 3 clones of both patient cell lines. iPSCs were further cultured on Matrigel (Corning) coated plates, using mTeSR1 medium (STEMCELL Technologies). Passaging was performed using a 5 min incubation with ReLeSR (STEMC-ELL Technologies) at 37°C. iPSCs were passaged 1:10-1:20 every 5-7 days and cultured at 37°C in 5% CO 2 .
Trilineage differentiation in vitro of hiPSCs
After incubation with Gentle Cell Dissociation Reagent (STEMCELL Technologies), undifferentiated hiPSC colonies were harvested and plated on Matrigel (Corning) coated glass coverslips according to the STEMdiff™ Trilineage Differentiation Kit protocol (STEMCELL Technologies). Medium was changed daily and hiPSCs were fixed with 2% paraformaldehyde (PFA) for immunofluorescent stainings after 5 (endoderm and mesoderm) and 7 days (ectoderm).
Immunofluorescent staining
After fixation in 2% PFA for 30 min at RT, the hiPSCs were permeabilized with 0.1% Triton X-100 for 1 h at RT. Next, the cells were incubated with blocking buffer (4% normal swine serum (NSS, DAKO)) for 1 h at RT. Primary antibody labeling, diluted in 4% NSS, was performed O/N at 4°C. After washing, the cells were incubated with secondary fluorescent antibodies for 1 h at RT. DAPI was used as a nuclear staining. Antibodies are listed in Table 3 . Images were obtained on a Leica TCS SP8 microscope.
RNA isolation and RT-qPCR
RNA isolation was performed using the ReliaPrep™ Miniprep System (Promega). In short, 500 ng RNA was used per reaction for cDNA synthesis, using the transcriptor first strand cDNA synthesis kit (Roche). RT-qPCR reactions were run, in 3 biological and 3 technical triplicates, on a LightCycler© 480 Real-Time PCR System (Roche), using SensiMix SYBR Hi-ROX kit (Bioline). Cycle parameters were: 10 min at 95°C and 45 cycles of 95°C for 10 s, 60°C for 30 s and 72°C for 20 s. CT-values were normalized to GAPDH, using the ΔΔCT-method. HiPSC line 114-2 was used as a positive control. As a negative control, fibroblast line 2B was used (Buijsen et al., 2018) . Primer sequences are listed in Table 3 .
Genomic DNA isolation
Genomic DNA isolation was performed using the Wizard Genomic DNA Purification Kit (Promega), according to manufacturer's instructions.
Repeat length PCR
The CAG repeat in the first exon of the HTT gene was amplified to confirm the genotype of the hiPSCs. Cycle parameters were: 4 min at 95°C and 35 cycles of 30 s at 95°C, 30 s at 59°C and 70 s at 72°C, ended by 7 min at 72°C. The PCR products were run on an ABI 3730 automatic DNA sequencer (Applied Biosystems, Foster City, CA, USA). As a control, hiPSC line 114-2 was used (Buijsen et al., 2018) . Primers are listed in Table 3 . 
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Fragment length analysis
Fragment length analysis was performed with OneTaq Master Mix (New England Biolabs) on an ABI genetic analyser (ThermoFisher). Cycle parameters were: 5 min at 94°C and 35 cycles of 30 s 94°C, 1 min 60°C and 2 min 68°C. Primers are listed in Table 3 .
Mycoplasma detection
To test the presence of mycoplasma, the MycoAlert™ Mycoplasma Detection Kit (Lonza) was used, according to manufacturer's instructions.
Global screening array
A Global screening array (GSA) (Illumina) was used according to standard protocols, followed by an analysis in GenomeStudio software (Illumina). The GenomeStudio Final reports were used to analyze and visualize the results in Nexus Discovery (BioDiscovery El Segundo). A report resolution of 50 kb was used to analyze the data for chromosomal aberrations. To compare the patient fibroblasts with the generated hiPSCs, the array final reports were selected as input for an R script. Using statistics we determined whether the allelic calls of the fibroblasts and hiPSCs matched, mismatched or failed.
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